SPOTLIGHT: Top 20 VC deals of 2007

2007 was another big venture capital year for biotech and medical device companies. Big Pharma's somewhat troubled pipelines contributed significantly to growth in venture investment. Venture capitalists, taking note of Big Pharma's seemingly insatiable appetite for all things biotech, boosted investment by 20 percent over last year, and biopharma and medical device companies raised a record $9.1 billion--almost a third of the total $29.4 billion invested in 2007. While VC funding comes in all shapes and sizes, the biggest deals often indicate which technologies are getting the most attention. Here's a look at the top 20 big winners from 2007. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.